Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Sanghavi Deep N.
Sem-1
Batch : 2018-19
Guided By :
Bhavnagar.
1
DR KALLAM ANJI REDDY
Birth : 1 February 1939 Guntur district, Andhra Pradesh, India
Died : 15 March 2013 Hyderabad, Andhra Pradesh (now Telangana),India
Nationality : Indian
Alma mater : Institute of Chemical Technology, Mumbai
National Chemical Laboratory, Pune
Occupation : Former Chairman, Dr. Reddy's Laboratories
Net worth(USD) : $1.39 Billion
Family : K Samrajyam (Wife)
Kallam Satish Reddy (Son)
G.Anuradha (Daughter)
G. V. Prasad (Son-In-Law)
2
BUSINESS SKILLS
Dr. Reddy started his career working for the state owned Indian Drugs and Pharmaceuticals Limited. He was the
founder managing director of Uniloids Ltd and worked there from 1976 to 1980 and Standard Organics Limited
where he worked from 1980 to 1984. In the year 1984, Dr. K. Anji Reddy laid the foundation of Dr. Reddy’s
Laboratories. The company established new standards in the Indian Pharmaceutical industry and transformed
the Indian bulk drug dependency of the mid-80s into a self-sufficient industry in the mid-90s. Finally the Indian
Pharmaceutical industry developed into an export-oriented industry and ever since continues to remain the
same.
Reddy started with two companies in his group Dr Reddy’s Labs and Cheminor. Recently they were merged. The
group has grown from a sales of Rs 103 crore in1991–92 to over 10 times that figure in less than 10 years. In fact
Profits too have grown from Rs 10 crore in 1991–92 to over Rs 300 crore. Interestingly, the year K. Anji Reddy
delivered the address was 1992. It is a classic example of the much-touted word “vision”. Dr Reddy’s
Laboratories had just crossed Rs 100 crore in sales that year and here was its chairman saying he could invest
Rs100 crore in the next 10 years and discover new drugs.
As a result his company, Dr Reddy’s Laboratories, stands tall in the Indian pharma sector in less than 10 years.
Although no drug has yet come out in the market from Reddy’s stable, many are in advanced trials all over the
world and major pharma companies like Novartis and Novo Nordisk are co-developing the drugs with him.
In the year 1993, Dr. Reddy’s Laboratories emerged as India’s first drug discovering company and on April 2001
it was the first non-Japanese, Asian pharmaceutical company which was listed on New York Stock Exchange.
3
ACHIEVEMENTS
Dr.Reddy is an active member of the Prime Minister’s Council on Trade & Industry. He has also been nominated
to the board of National Institute of Pharmaceutical Education and Research (NIPER).
A generous donor Dr. K. Anji Reddy has also founded the Dr. Reddy’s Foundation for Human & Social
Development, which works as a medium to bring about change in order to prop up development.
In his huge career Dr. K. Anji Reddy has been the recipient of many awards and civic honors. These include:
Sir PC Ray Award in 1984 & 1992
FAPA-Ishidate Award for Pharmaceutical Research in 1998
Padma Shri award in 2000
Achiever of the Year Award, 2000
Businessman of the Year in 2001
Padma Bhushan in 2011
Member of the Indian Prime Minister's Council on Trade and Industry.
Gauri Kamath published his biography namely “An Unfinished Agenda”.
4
5
QUOTES
“ I always wanted to start something where others felt there was a barrier to tackle”
“It was a dream. It was not a plan on the drawing board, no. But it was a dream.”
“My father used to administer herbal medicine for free. But I can't give drugs for free. So the next best thing is
to give it at as low a price as possible.”
“I want to build a company that’d last 500 years”
“We earned our dollars in a hard way ;nobody gave us a feast or gave it on a plate. We worked hard and we
have innovated; we have made things in a better way at a cheaper rate and gave it to the people of India”
No wonder that when Anji Reddy addressed the Ficci CEO conference on ‘Building a research-based
pharmaceutical company’, his theme was: “Size does not matter”. This time every one in the audience took this
diminutive and feisty technocrat seriously.
6
BUSINESS MILESTONES
1984 - Establishment of Dr Reddy’s Laboratories
1986 - Stepped into International Market.
1988 - Merged Bembex Labs
1990 - Started exporting drugs to Europe and Eastern Companies.
1993 - Establishement of Research Foundation
1995 – Tied up with few Russian Companies.
2001 - Patent for some Generic drugs in America.
2002 – Listed in New York Stock Exchange
2006 - Merged German Company Betaform
7
SOCIAL SERVICES
DR REDDY’S FOUNDATION (DRF)
NICE FOUNDATION
NAANDI Charitable Trust
Pudami Schools
School Improvement Program
KARV College
Teach For India
8
SUCCESSOR DEVELOPMENT
The 73 year old, first generation entrepreneur breathed his last in the Apollo Hospitals. His son, Kallam Satish Reddy
took over as Managing Director and Chief Operating Officer. Daughter, Anuradha heads the Dr Reddy’s Foundation. His
son-in-law, G.V Prasad is the Vice Chairman and Chief Executive Officer of the company.
G.V. PRASAD
Alma mater : Purdue University
Illinois Institute of Technology
Alagappa College of Technology
His first exposure to the world of pharmaceuticals was in 1985 with Benzex Labs, a pharmaceutical enterprise
that he co-founded. Benzex was later acquired by Dr. Reddys and Prasad returned to the construction business,
only to come back to pharmaceuticals in 1990 – this time as the CEO and MD of Cheminor Drugs Ltd. In 2001,
Cheminor Drugs merged with Dr.Reddy's Laboratories and Prasad took over as the vice-chairman and CEO of the
merged entity.
Since 1993, Reddy was the executive director in charge of the manufacturing operations of active
pharmaceutical ingredients and formulations, research and development activities and new product
development at Dr. Reddy's Laboratories Ltd and also served as its chief operating officer. In 2015, he was
appointed as the Chief of National Safety Council (India).
ANURADHA GUNUPATI
Anuradha Gunupati is the Founder Trustee of Dr. Reddy’s Foundation. Her commitment to ensure quality
education for kids, irrespective of their economic status, led to the establishing of the Pudami schools for the
urban poor.
A keen lover of arts and culture, she is the founder of Saptaparni, an organization dedicated to promoting Indian
performing arts, culture and heritage. In an effort to continue the philanthropic legacy of her father Dr. Kallam
Anji Reddy she has established the KARA festival – a platform for interaction, learning and promoting the joy of
art while raising funds for organizations making a difference in the fields of education and health.
9
REFERENCES
https://en.wikipedia.org/wiki/Kallam_Anji_Reddy (2-12-18)
https://drreddysfoundation.org/ (2-12-18)
http://www.drreddys.com/our-story/our-heritage/our-founder (2-12-18)
https://en.wikipedia.org/wiki/Kallam_Satish_Reddy (3-12-18)
https://www.businesstoday.in/A/focus/obituary-k.-anji-reddy/story/193603.html (3-12-18)
https://en.wikipedia.org/wiki/G._V._Prasad (3-12-18)
10